Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Immunity
|
April 9, 2025
More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade
Daniel H Shu, Mark Yarchoan
Methods in Molecular Biology (Clifton, N.J.)
|
November 11, 2024
Maturation of Tertiary Lymphoid Structures
Daniel H Shu, Dimitrios N Sidiropoulos
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 26, 2016
Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon
Wen-Hai Shao, Daniel H Shu, Yuxuan Zhen, et al.
Nature Medicine
|
April 7, 2024
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Mark Yarchoan, Edward J Gane, Thomas U Marron, et al.
The Lancet. Oncology
|
October 22, 2024
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
Antonio D'Alessio, Bernardo Stefanini, Julia Blanter, et al.
Journal of Hepatology
|
November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC
Zeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Nature Communications
|
April 21, 2025
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors
Chester Kao, Soren Charmsaz, Hua-Ling Tsai, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders
Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Nature Communications
|
February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Immunity
|
April 9, 2025
More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade
Daniel H Shu, Mark Yarchoan
Methods in Molecular Biology (Clifton, N.J.)
|
November 11, 2024
Maturation of Tertiary Lymphoid Structures
Daniel H Shu, Dimitrios N Sidiropoulos
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 26, 2016
Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon
Wen-Hai Shao, Daniel H Shu, Yuxuan Zhen, et al.
Nature Medicine
|
April 7, 2024
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Mark Yarchoan, Edward J Gane, Thomas U Marron, et al.
The Lancet. Oncology
|
October 22, 2024
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
Antonio D'Alessio, Bernardo Stefanini, Julia Blanter, et al.
Journal of Hepatology
|
November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC
Zeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Nature Communications
|
April 21, 2025
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors
Chester Kao, Soren Charmsaz, Hua-Ling Tsai, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders
Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Nature Communications
|
February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Page
of 2